While sarkosyl is a useful reagent for isolating tau aggregates across a range of neurodegenerative diseases, it's established that sarkosyl isolation is not comprehensive for all tau isoforms present in the brain due to differences in the biochemical properties, phosphorylation and aggregation states of tau. This evidence concerns the gene MAPT and neurodegenerative disease.